𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Inhaled tobramycin reduces hospitalisation in cystic fibrosis

✍ Scribed by McClellan, Karen

Book ID
121643517
Publisher
Adis International Limited (now part of Wolters Kluwer Health)
Year
1999
Weight
116 KB
Volume
195
Category
Article
ISSN
1173-5503

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Reduced mortality in cystic fibrosis pat
Reduced mortality in cystic fibrosis patients treated with tobramycin inhalation solution
✍ Gregory S. Sawicki; James E. Signorovitch; Jie Zhang; Dominick Latremouille-Viau πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 110 KB

## Abstract ## Background Though tobramycin inhalation solution has been used for over a decade to improve lung function and reduce exacerbations in patients with cystic fibrosis (CF), its effects on mortality have not been well‐described. This study aimed to assess the association between use of

Inhaled tobramycin and bronchial hyperac
Inhaled tobramycin and bronchial hyperactivity in cystic fibrosis
✍ Maya Ramagopal; Larry C. Lands πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 60 KB

The use of inhaled tobramycin for prophylaxis and treatment of respiratory symptoms in cystic fibrosis (CF) is now widespread. There have been concerns that inhaling the intravenous (I.V.) formulation of tobramycin causes bronchoconstriction. Previous studies using this formulation have either not s